Cancer Biology and Medicine,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 18
Published: June 28, 2024
Gastric
cancer
(GC)
is
a
major
cause
of
cancer-related
mortality
worldwide.
This
determined
by
multiple
(epi)genetic
and
environmental
factors;
can
occur
at
distinct
anatomic
positions
the
stomach;
displays
high
heterogeneity,
with
different
cellular
origins
diverse
histological
molecular
features.
heterogeneity
has
hindered
efforts
to
fully
understand
pathology
GC
develop
efficient
therapeutics.
In
past
decade,
great
progress
been
made
in
study
GC,
particularly
subtyping,
investigation
immune
microenvironment,
defining
evolutionary
path
dynamics.
Preclinical
mouse
models,
immunocompetent
models
that
mimic
features
human
combination
organoid
culture
clinical
studies,
have
provided
powerful
tools
for
elucidating
mechanisms
underlying
evasion,
development
novel
therapeutic
strategies.
Herein,
we
first
briefly
introduce
current
challenges
subsequently
summarize
emphasizing
potential
application
genetically
engineered
antitumor
immunity
immunotherapy
studies.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Feb. 21, 2024
Gut
microbiota
can
adapt
to
their
host
environment
by
rapidly
acquiring
new
mutations.
However,
the
dynamics
of
this
process
are
difficult
characterize
in
dominant
gut
species
complex
vivo
environment.
Here
we
show
that
fine-scale
genome-wide
transposon
libraries
enable
quantitative
inferences
these
evolutionary
forces.
By
analyzing
>400,000
lineages
across
four
human
Bacteroides
strains
gnotobiotic
mice,
observed
positive
selection
on
thousands
cryptic
variants
-
most
which
were
unrelated
original
gene
knockouts.
The
spectrum
fitness
benefits
varied
between
species,
and
displayed
diverse
tradeoffs
over
time
different
dietary
conditions,
enabling
underlying
function.
These
results
suggest
within-host
adaptations
arise
from
an
intense
competition
numerous
contending
variants,
strongly
influence
emergent
tradeoffs.
Nature Cancer,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 1, 2024
Carcinogenesis
results
from
the
sequential
acquisition
of
oncogenic
mutations
that
convert
normal
cells
into
invasive,
metastasizing
cancer
cells.
Colorectal
exemplifies
this
process
through
its
well-described
adenoma-carcinoma
sequence,
modeled
previously
using
clustered
regularly
interspaced
short
palindromic
repeats
(CRISPR)
to
induce
four
consecutive
in
wild-type
human
gut
organoids.
Here,
we
demonstrate
long-term
culture
mismatch-repair-deficient
organoids
allows
selection
spontaneous
withdrawal
Wnt
agonists,
epidermal
growth
factor
(EGF)
agonists
and
bone
morphogenetic
protein
(BMP)
antagonist
Noggin,
while
TP53
were
selected
addition
Nutlin-3.
Thus,
sequentially
acquired
AXIN1
AXIN2
(Wnt
pathway),
TP53,
ACVR2A
BMPR2
(BMP
pathway)
NRAS
(EGF
gaining
complete
independence
stem
cell
niche
factors.
Quadruple-pathway
(Wnt,
EGF
receptor,
p53
BMP)
mutant
formed
solid
tumors
upon
xenotransplantation.
This
demonstrates
carcinogenesis
can
be
recapitulated
a
DNA
repair-mutant
background
vitro
targets
pathways.
Chromosome Research,
Journal Year:
2023,
Volume and Issue:
31(4)
Published: Oct. 21, 2023
Aneuploidy-the
karyotype
state
in
which
the
number
of
chromosomes
deviates
from
a
multiple
haploid
chromosome
set-is
common
cancer,
where
it
is
thought
to
facilitate
tumor
initiation
and
progression.
However,
poorly
tolerated
healthy
cells:
during
development
tissue
homeostasis,
aneuploid
cells
are
efficiently
cleared
population.
It
still
largely
unknown
how
cancer
become,
adapt
being,
aneuploid.
P53,
gatekeeper
genome,
has
been
proposed
guard
against
aneuploidy.
Aneuploidy
genomes
strongly
correlates
with
mutations
TP53,
p53
prevent
propagation
cells.
Whether
also
participates
preventing
mistakes
cell
division
that
lead
aneuploidy
under
debate.
In
this
review,
we
summarize
current
understanding
role
protecting
aneuploidy,
explore
consequences
functional
loss
for
cancer.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 26, 2025
Cancer
cells
exhibit
high
heterogeneity
and
lineage
plasticity,
complicating
studies
of
tumorigenesis
development
therapies.
Recently,
preneoplastic
cells,
although
histologically
normal,
have
been
shown
to
possess
plasticity
early
genetic
alterations,
yet
their
origins
trajectories
remain
unclear.
Herein,
we
introduce
a
lineage-tracing
tool
integrating
barcoding
with
single-cell
RNA
sequencing
map
esophageal
cell
lineages.
We
identified
precursor
(PNPCs)
as
distinct
progenitor-like
population
unique
transcriptional
profiles
contributing
proliferative
basal
populations.
To
enhance
mapping,
developed
the
eXamined
Ridge
(XR)
score,
accurately
identifying
high-plasticity
cells.
Nfib
Qk
emerged
conserved
PNPC
markers,
peaking
in
preneoplasia
declining
after
malignant
transformation.
These
findings
reveal
PNPCs
key
players
highlight
potential
biomarkers
for
cancer
detection
therapeutic
intervention,
offering
new
strategies
preventing
progression.
Biofabrication,
Journal Year:
2025,
Volume and Issue:
17(2), P. 022008 - 022008
Published: Feb. 28, 2025
In
recent
years,
biofabrication
technologies
have
garnered
significant
attention
within
the
scientific
community
for
their
potential
to
create
advancedin
vitrocancer
models.
While
these
been
predominantly
applied
model
advanced
stages
of
cancer,
there
exists
a
pressing
need
develop
pertinent,
reproducible,
and
sensitive
3D
models
that
mimic
cancer
initiation
lesions
native
tissue
microenvironment.
Such
hold
profound
relevance
comprehending
intricacies
initiation,
devise
novel
strategies
early
intervention,
and/or
conduct
sophisticated
toxicology
assessments
putative
carcinogens.
Here,
we
will
explain
pivotal
factors
must
be
faithfully
recapitulated
when
constructing
models,
with
specific
focus
on
pancreatic
lesions.
By
synthesizing
current
state
research
in
this
field,
provide
insights
into
advances
breakthroughs.
Additionally,
delineate
key
technological
biological
challenges
necessitate
resolution
future
endeavors,
thereby
paving
way
more
accurate
insightfulin
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 26, 2025
Brain
metastases
in
esophageal
adenocarcinoma
(EAC)
patients
are
associated
with
poor
prognosis
and
remain
understudied.
We
performed
multi-omics
analysis
whole-genome
sequencing
single-cell
spatial
transcriptomics
on
the
brain
matched
primary
tumors.
Our
identified
ERBB2
as
a
recurrent
oncogene
EAC
metastases,
9
out
of
10
cases
harboring
amplifications.
Single-cell
multi-region
revealed
that
alterations,
occur
early
during
disease
progression
monoclonal
seeding.
Although
median
survival
our
cohort
was
13
months,
one
patient
HER2
antibody-drug
conjugate
therapy
remains
long-term
survivor
beyond
34
months.
Interestingly,
sole
without
an
alteration
had
JAK2
deletion,
high
T
cell
infiltration
lesion,
survived
35
months
after
immune
checkpoint
therapy.
findings
have
significant
clinical
implications
for
treatment
management
metastases.
is
targetable
EAC-BM
High
-deleted
tumor
links
to
immunotherapy
response
Genomic
instability
marked
by
presence
micronuclei
ecDNAEAC
metastasis
resembles
seeding
events.